尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Moran Susan. Insider active across 2 companies, notably RayzeBio, Inc.. Aggregated, 4 filings have been published. Activity tracked since 22 January 2024. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Moran Susan is a declarant linked to BioAtla, Inc., where she is a Director, and to RayzeBio, Inc., where she is CHIEF MEDICAL OFFICER. She has 4 filings in total, and across the sampled recent filings the sell amount is EUR 18683772, with filings ranging from 2024-02-06 to 2025-06-18. The modal transaction nature is Attribution.